2013 & 2014 Events and Conferences

Date

Event

Location

 

January 19-23, 2013

SCCM 2013

Abstract :Bacteremic Sepsis: Can Treatment Duration Be Shortened By the Use of Sequential Procalcitonin and Endotoxin? A Prospective Double-Blind Cohort Study.
990: Kalil, Andre; Florescu, Diana; Haynatzki, Gleb; Shafer, Laura; Chambers, Heather; Hill, Lisa; Schooneveld, Trevor Van

San Juan, PR

January 25-26, 2013

Endotoxemia in Critical Care 2013

Abstract: The EUPHRATES Trial (Evaluating the Use of  Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock):  Protocol for a Blinded Theragnostic Multi-centered Randomized Controlled Trial
Walker PM, Klein DJ, Foster D, Marshall JC, Schorr K, Dellinger RP

Tokyo, JP

February 12-15, 2013

CRRT 2013

February 14 @ 12:40 Focus Group Luncheon:
Endotoxemia is Related to Sepsis, Sepsis is Related to AKI, ergo...Endotoxemia is Related to AKI?
David J Klein, Walker M Paul

February 15 @ 10:45 Plenary 7 MINI SYMPOSIA:
Emerging Strategies in AKI and Extracorporeal Support
(Part 5. Polymixin Binding Filter for Sepsis: EUPHRATES Trial )
S. Bagshaw

Abstract: The EUPHRATES Trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): A Blinded Theragnostic Hemoperfusion Trial
David J Klein, Walker M Paul, Foster Debra, Marshall C John, Schorr Christina, Dellinger P R

San Diego, CA

March 19-22, 2013

ISICEM
International Syposium on Intensive Care and Emergency Medicine
Visit out partner, Toray Medical at exhibit stand no. 1.35

Brussels, Belgium

May 23, 2013 @ 4:00pm

Annual General Meeting of Shareholders
Stikeman Elliott LLP, 5300 Commerce Court West,
199 Bay Street

Toronto, ON

June 11-14, 2013

Vicenza Nephrology Courses

Friday June 14th, 12:00-1:30pm, Satellite Symposium Session 12B: Endotoxin Removal

Vicenza, Italy

June 12-15, 2013

ASAIO 2013
American Society for Artificial Internal Organs

Friday June 14th, 1:30-3:15, as part of the session:
Novel Extracorporeal Support in SIRS Pathophysiology, Polymyxin B Hemoperfusion For The Treatment Of Severe Sepsis
Gualtiero Guadagni, Ph.D

Saturday June 15th, 8am-12pm, Abstract Presentation: Polymyxin B-Hemoperfusion And Endotoxin Activity Assay In Kidney Transplants
Vincenzo Morabito, MD

Chicago, IL

August 14, 2013

Wedbush Life Sciences Management Access Conference Presentation

 

September 13, 2013

World Sepsis Day

 

October 5-9, 2013

ESICM
Presentations:

October 7th:
Dr. G. Li Bassi et al. (Spain, No. 477); Polymyxin B hemoperfusion in an animal model of severe P. Aeruginosa pneumonia: preliminary results on endotoxemia and hemodynamics.

Dr. S. Yoshida et al. (Japan, No.1573); Evaluation of the effect of polymyxin B direct hemoperfusion on improvement hemodynamic instability in patients with septic shock.

October 8th:
Dr. R. Ferrer (Spain, the session of PERSONALISED TREATMENT IN SEPSIS); Endotoxin removal.

October 9th"
Dr. A. Navas, et al. (Spain, No. 1041); Cost of managing severe sepsis patients treated with Toraymyxin in Spain.

Paris, FR

November 9-12, 2013

Critical Care Canada Forum
Visit us: Booth #27

Monday November 11th @ 8:30 - 10am
Presentation:
Endotoxin removal in gram negative sepsis (as part of the session Cutting Edge Infections)
M. Antonelli.

Toronto, ON

January 9-13, 2014

Society of Critical Care Medicine Congress

Visit us: Booth #1130

San Francisco, CA

March 4-7, 2014

CRRT 2014
Acute Kidney Injury: Controversies, Challenges and Solutions. Advances in Critical Care

Focus Group Luncheon: Endotoxin Measurements and Treatment for Endotoxemia: Who, How, What and Why
Thursday, March 6, 2014 - 12:40pm-2:00pm

Plenary 7 MINI SYMPOSIA: Emerging Strategies in AKI and Extracorporeal Support
Friday, March 7, 2014 - 10:45am-1:00pm

San Diego, CA

March 18-21, 2014

ISICEM 2014
34th International Symposium on Intensive Care and Emergency Medicine

Visit our Partners: Toray, Exhibition Stand No. 2.06

Brussels, BE

May 5, 2014 @4:00pm

Annual General Meeting of Shareholders
The offices of Stikeman Elliott LLP
Suite 5300, 199 Bay Street, Toronto, Ontario

Toronto, ON

© 2011 Spectral Diagnostics Inc.